LISATA THERAPEUTICS, INC. Amortization of Debt Issuance Costs and Discounts
LISATA THERAPEUTICS, INC. (LSTA) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2015-03-02
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for fiscal 2014 was $0.00.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for fiscal 2012 was $1.61M, a 34.04% decline from fiscal 2011.
- LISATA THERAPEUTICS, INC. amortization of debt issuance costs and discounts for fiscal 2011 was $2.44M.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-02 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $414.28K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | $414.28K derived: sum of 3 quarters · filed 2015-03-02 | $736.76K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $414.28K derived: sum of 2 quarters · filed 2015-03-02 | $736.76K derived: sum of 3 quarters · filed 2015-03-02 | $1.14M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $414.28K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $736.76K derived: sum of 2 quarters · filed 2015-03-02 | $1.14M derived: sum of 3 quarters · filed 2015-03-02 | $1.61M 10-K · filed 2015-03-02 |
| 2012-09-30 | $322.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $723.28K derived: sum of 2 quarters · filed 2013-11-07 | $1.20M 10-Q · filed 2013-11-07 | $1.73M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $400.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $872.74K 10-Q · filed 2013-08-08 | $1.41M derived: sum of 3 quarters · filed 2013-08-08 | $1.98M derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | $471.93K 10-Q · filed 2013-05-09 | $1.01M derived: sum of 2 quarters · filed 2013-05-09 | $1.58M derived: sum of 3 quarters · filed 2013-05-09 | $2.24M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $536.54K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $1.11M derived: sum of 2 quarters · filed 2013-03-11 | $1.76M derived: sum of 3 quarters · filed 2013-03-11 | $2.44M 10-K · filed 2013-03-11 |
| 2011-09-30 | $574.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $1.23M derived: sum of 2 quarters · filed 2012-11-13 | $1.90M 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $653.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.33M 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $676.12K 10-Q · filed 2012-05-11 | |||
| 2010-12-31 | $281.21K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |